Company Filing History:
1 out of 67 
1 out of 11 
1 out of 265 
Years Active: 2019
Title: Jacob Christian Fredsøe: Innovator in Prostate Cancer Detection
Introduction
Jacob Christian Fredsøe is a notable inventor based in Risskov, Denmark. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of prostate cancer. His innovative approach utilizes microRNA to assess cancer risk through urine samples, showcasing the intersection of biotechnology and healthcare.
Latest Patents
Jacob Christian Fredsøe holds a patent for a microRNA-based method for early detection of prostate cancer in urine samples. This method involves measuring the expression levels of at least two specific microRNAs, which are crucial indicators of prostate cancer risk. The patent emphasizes the importance of these biomarkers in providing a non-invasive diagnostic tool for patients.
Career Highlights
Throughout his career, Fredsøe has worked with prominent institutions such as Aarhus University and Region Midtjylland. His work has focused on advancing medical research and developing innovative diagnostic methods that can improve patient outcomes.
Collaborations
Jacob has collaborated with talented individuals in his field, including Anni Rønfeldt Thomsen and Karina Dalsgaard Sørensen. These partnerships have contributed to the success of his research and the development of his patented methods.
Conclusion
Jacob Christian Fredsøe is a pioneering inventor whose work in microRNA-based diagnostics is paving the way for more effective prostate cancer detection methods. His contributions to medical science highlight the importance of innovation in improving healthcare solutions.